Scholarlink

<p>Alternatively activated M2-like macrophages have a profound impact on asthma pathogenesis. Basic Helix-Loop-Helix Family Member E40 (BHLHE40), a dimeric transcriptional factor, plays a key regulation in macrophage functions. Here we show that ovalbumin (OVA)-challenged mice exhibited greater expression of BHLHE40 in lung tissues. <i>Bhlhe40</i> knockdown reduced the pulmonary lesions and allergy-induced inflammation in asthmatic mice. Moreover, an inhibitory effect of <i>Bhlhe40</i> knockdown on alternative activation was observed in vivo and in vitro. We show a downstream target Neurturin (<i>Nrtn</i>) of <i>Bhlhe40</i>. Dual luciferase assay and ChIP-qPCR assay indicated that BHLHE40 bound to <i>Nrtn</i> promoter and reduced its transcriptional activity. Simultaneous knockdown of <i>Bhlhe40</i> and <i>Nrtn</i> recovered the alternative activation of macrophages and rescued the OVA-elicited asthma phenotype. NRTN downregulation offset the alleviative effects of <i>Bhlhe40</i> knockdown on asthma. This study demonstrates that BHLHE40 promotes allergic asthma, and contributes to the alternative activation of macrophages in asthma by inhibiting <i>Nrtn</i> transcription.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

BHLHE40 contributes to allergic asthma progression in mice through NRTN downregulation in macrophages

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年6月4日

查看全文
  • Bing Dai,
  • Li Chen,
  • Xiaowen Li,
  • Qianlan Zhou,
  • Qinzhen Zhang,
  • Lina Han,
  • Wenxin Shen,
  • Qing Chang,
  • Yuhong Zhao,
  • Si Liu,
  • Lishen Shan

摘要

Alternatively activated M2-like macrophages have a profound impact on asthma pathogenesis. Basic Helix-Loop-Helix Family Member E40 (BHLHE40), a dimeric transcriptional factor, plays a key regulation in macrophage functions. Here we show that ovalbumin (OVA)-challenged mice exhibited greater expression of BHLHE40 in lung tissues. Bhlhe40 knockdown reduced the pulmonary lesions and allergy-induced inflammation in asthmatic mice. Moreover, an inhibitory effect of Bhlhe40 knockdown on alternative activation was observed in vivo and in vitro. We show a downstream target Neurturin (Nrtn) of Bhlhe40. Dual luciferase assay and ChIP-qPCR assay indicated that BHLHE40 bound to Nrtn promoter and reduced its transcriptional activity. Simultaneous knockdown of Bhlhe40 and Nrtn recovered the alternative activation of macrophages and rescued the OVA-elicited asthma phenotype. NRTN downregulation offset the alleviative effects of Bhlhe40 knockdown on asthma. This study demonstrates that BHLHE40 promotes allergic asthma, and contributes to the alternative activation of macrophages in asthma by inhibiting Nrtn transcription.